APA (7th ed.) Citation

L, D., A, O., M, D., C, S., P, H., N, S., . . . T, Z. (2026). Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database. Targeted oncology, 21(3), 411. https://doi.org/10.1007/s11523-026-01211-6

Chicago Style (17th ed.) Citation

L, Dreikhausen, et al. "Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database." Targeted Oncology 21, no. 3 (2026): 411. https://doi.org/10.1007/s11523-026-01211-6.

MLA (9th ed.) Citation

L, Dreikhausen, et al. "Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database." Targeted Oncology, vol. 21, no. 3, 2026, p. 411, https://doi.org/10.1007/s11523-026-01211-6.